Journal article
Outcomes of Growth Hormone Replacement Therapy in Survivors of Childhood Acute Lymphoblastic Leukemia
Journal of clinical oncology, v 20(13), pp 2959-2964
01 Jul 2002
PMID: 12089225
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
PURPOSE: Little is known about the long-term efficacy or adverse effects of growth hormone (GH) replacement therapy in survivors of childhood acute lymphoblastic leukemia (ALL) who have GH deficiency. We investigated the adult height of patients who had received GH and estimated their risk of leukemia relapse or development of a second malignancy.
PATIENTS AND METHODS: Of 910 patients treated for ALL at a single institution, 47 had received GH replacement therapy. The linear growth of these 47 patients was retrospectively evaluated. Their risk of leukemia relapse or second malignancy was compared with that of survivors who did not undergo GH therapy.
RESULTS: The median height SD score at the start of GH therapy had decreased by 1.0 since the time of diagnosis of ALL. After a median duration of 4.5 years of GH therapy, adult height SD scores improved and approached height SD scores at the time of diagnosis of ALL. The median adult height for male patients was 173.2 cm (range, 157 to 191.9 cm), and for female patients, it was 158.1 cm (range, 141 to 168 cm). None of the patients developed adverse effects requiring discontinuation of GH treatment. At the 7-year and 11-year landmarks in continuous hematologic remission, there was no statistical evidence that GH therapy was associated with leukemia relapse or development of a second malignancy.
CONCLUSION: This study suggests that GH replacement therapy is safe and efficacious for the correction of GH deficiency in survivors of childhood ALL.
Metrics
Details
- Title
- Outcomes of Growth Hormone Replacement Therapy in Survivors of Childhood Acute Lymphoblastic Leukemia
- Creators
- Wing Leung - St. Jude Children's Research HospitalSusan R. Rose - St. Jude Children's Research HospitalYinmei Zhou - St. Jude Children's Research HospitalMichael L. Hancock - St. Jude Children's Research HospitalStephen Burstein - St. Jude Children's Research HospitalElizabeth A. Schriock - St. Jude Children's Research HospitalRobert Lustig - St. Jude Children's Research HospitalRobert K. Danish - St. Jude Children's Research HospitalWilliam E. Evans - St. Jude Children's Research HospitalMelissa M. Hudson - St. Jude Children's Research HospitalChing-Hon Pui
- Publication Details
- Journal of clinical oncology, v 20(13), pp 2959-2964
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Web of Science ID
- WOS:000176583400008
- Scopus ID
- 2-s2.0-0036645443
- Other Identifier
- 991021448044704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology